Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0LSCJI)
| ADC Name |
HER2-DL012-DAR2
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
HER2-DL012-DAR2
Click to Show/Hide
|
|||||
| Organization |
Suzhou Medilink Therapeutics Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.8
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
DL012-payload
|
Payload Info | ||||
| Linker Name |
DL012-Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
DL012
|
|||||